TREATMENT PATTERNS AND REAL-LIFE RESPONSE IN PATIENTS WITH RELAPSED/REFRACTORY CUTANEOUS T-CELL LYMPHOMA: CLINICAL PRACTICE DATA IN SPAIN

被引：0
|
作者：
Ortiz-Romero, P. [1 ]
Pimpinelli, N. [2 ]
Illidge, T. [3 ]
Bagot, M. [4 ]
Waser, N. [5 ]
He, M. [5 ]
Zomas, A. [6 ]
Gavini, F. [6 ]
Trinchese, F. [6 ]
Little, M. [7 ]
Dalal, M. [7 ]
Assaf, C. [8 ]
机构：
[1] Hosp Univ 12 Octubre, Fac Med, Inst I 12, CIBERONC, Madrid, Spain
[2] Univ Florence, Dept Hlth Sci, Florence, Italy
[3] Univ Manchester, Christie Hosp, NIHR Biomed Ctr, Manchester, Lancs, England
[4] Hop St Louis, Polyclin Dermatol, Paris, France
[5] ICON Plc, Real World Evidence Strategy & Analyt, Vancouver, BC, Canada
[6] Takeda Pharmaceut Int AG, Zurich, Switzerland
[7] Millennium Pharmaceut Inc, Cambridge, MA USA
[8] HELIOS Klinikum Krefeld, Krefeld, Germany
来源：
HAEMATOLOGICA | 2020年 / 105卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO-276
引用
收藏
页码：313 / 313
页数：1
相关论文
共 50 条
  • [1] Romidepsin treatment for relapsed or refractory peripheral and cutaneous T-cell lymphoma: Real-life data from a national multicenter observational study
    Shimony, Shai
    Horowitz, Netanel
    Ribakovsky, Elena
    Rozovski, Uri
    Avigdor, Abraham
    Zloto, Keren
    Berger, Tamar
    Avivi, Irit
    Perry, Chava
    Abadi, Uri
    Raanani, Pia
    Gafter-Gvili, Anat
    Gurion, Ronit
    HEMATOLOGICAL ONCOLOGY, 2019, 37 (05) : 569 - 577
  • [2] Contemporary treatment patterns and response in relapse/refractory cutaneous T-cell lymphoma (CTCL) in clinical practice in France, Germany Italy, Spain and the United Kingdom
    Illidge, T.
    Bagot, M.
    Waser, N.
    He, M.
    Li, T.
    Sambrook, R.
    Zomas, A.
    Trinchese, F.
    Gavini, F.
    Little, M.
    Ortiz, P.
    Pimpinelli, N.
    Dalal, M.
    Assaf, C.
    EUROPEAN JOURNAL OF CANCER, 2019, 119 : S36 - S36
  • [3] Cognition/Psychological Burden and Resilience in Cutaneous T-Cell Lymphoma and Psoriasis Patients: Real-Life Data and Implications for the Treatment
    Damiani, Giovanni
    Tacastacas, Joselin D.
    Wuerz, Timothy
    Miller, Lindsay
    Fastenau, Philip
    Bailey, Christopher
    Chawa, Mansi Sethi
    Argenas, Amanda
    Fiore, Marco
    Cooper, Kevin D.
    Lerner, Alan J.
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [4] Contemporary Treatment Patterns and Response in Relapsed/Refractory Cutaneous T-Cell Lymphoma (CTCL) across Five European Countries
    Assaf, Chalid
    Waser, Nathalie
    Bagot, Martine
    He, Mary
    Li, Tina
    Dalal, Mehul
    Gavini, Francois
    Trinchese, Fabrizio
    Zomas, Athanasios
    Little, Meredith
    Pimpinelli, Nicola
    Ortiz-Romero, Pablo L.
    Illidge, Timothy M.
    CANCERS, 2022, 14 (01)
  • [5] Mogamulizumab Monotherapy in the Treatment of Relapsed/Refractory Peripheral T-Cell Lymphoma or Cutaneous T-Cell Lymphoma Patients in Single-Institution Experience
    Murai, Kazunori
    Hiroyuki, Hamada
    Sato, Akiyoshi
    Yasuro, Miyairi
    Mori, Yasuki
    Sakuma, Tsutomu
    BLOOD, 2017, 130
  • [6] PRALATREXATE EFFICACY AND TOLERABILITY IN PATIENTS WITH RELAPSED OR REFRACTORY CUTANEOUS T-CELL LYMPHOMA (CTCL)
    Horwitz, M.
    Duvic, M.
    Kim, Y.
    Zain, J.
    Lechowiz, M.
    Koutsoukos, T.
    Fruchtman, S.
    O'Connor, O.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 120 - 120
  • [7] Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma
    Zinzani, Pier Luigi
    Salles, Gilles
    Moskowitz, Alison J.
    Santoro, Armando
    Mehta, Amitkumar
    Barr, Paul M.
    Mehta-Shah, Neha
    Collins, Graham P.
    Ansell, Stephen M.
    Brody, Joshua D.
    Domingo-Domenech, Eva
    Johnson, Nathalie A.
    Cunningham, David
    Ferrari, Silvia
    Lisano, Julie
    Krajewski, Jennifer
    Wen, Rachael
    Akyol, Alev
    Crowe, Russell
    Savage, Kerry J.
    BLOOD ADVANCES, 2024, 8 (10) : 2400 - 2404
  • [8] Characterizing the belinostat response in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma
    Sawas, Ahmed
    Ma, Helen
    Shustov, Andrei
    Hsu, Pamela
    Bhat, Gajanan
    Acosta, Mark
    Horwitz, Steven
    O'Connor, Owen A.
    LEUKEMIA & LYMPHOMA, 2020, 61 (08) : 2003 - 2007
  • [9] Gemcitabine, Navelbine, and Doxorubicin as Treatment for Patients with Refractory or Relapsed T-Cell Lymphoma
    Qian, Zhengzi
    Song, Zheng
    Zhang, Huilai
    Wang, Xianhuo
    Zhao, Jing
    Wang, Huaqing
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [10] Pralatrexate injection for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma
    Jennifer, Zhao C.
    Sara Mohamed, Jaszczur
    Salma, Afifi
    Francine, Foss
    EXPERT REVIEW OF HEMATOLOGY, 2020, 13 (06) : 577 - 583
12345